| For: | Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686 [PMID: 31602167 DOI: 10.3748/wjg.v25.i37.5676] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm |
| Number | Citing Articles |
| 1 |
Hirsh D. Trivedi, Emily W. Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D. Feuerstein, Theodore T. Pierce. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2023; 57(6) doi: 10.1097/MCG.0000000000001727
|
| 2 |
Shaya Noorian, Yejoo Jeon, Minh T Nguyen, Jenny Sauk, Berkeley N Limketkai. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. Inflammatory Bowel Diseases 2022; 28(6) doi: 10.1093/ibd/izab199
|
| 3 |
Yuanshan Xu, Youting Yi, Xiankang Zhang, Boyi Jia, Yanrong Huang, Renyun Cui, Haowen Sun, Meng Wang, Jin-Yi Wan, Haiqiang Yao, Chun-Su Yuan. Global burden of MASLD-IBD comorbidity from 1990 to 2021 and trend prediction to 2050. International Journal of Surgery 2026; 112(1) doi: 10.1097/JS9.0000000000003383
|
| 4 |
Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain. Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2024.00001
|
| 5 |
|
| 6 |
Ji-Yeon Park, Hye-Seon Jeong, Seong-Ryeong Lim, Won-Kyo Jung, Jae-Young Je, Chang-Hyung Choi, Sei-Jung Lee. Triple-emulsion microfluidic Core–Shell hydrogel microcapsules for oral pentoxifylline Delivery: Ameliorating colitis and rebalancing gut microbiome. Materials Today Bio 2026; 37 doi: 10.1016/j.mtbio.2026.102881
|
| 7 |
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, Wei Qiu, Yuguo Chen, Jianpeng Zhou, Guoyue Lv. Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.891410
|
| 8 |
Anastasia Postoev, Abebe Yigzaw, Helai Hussaini, Olaniyi Fadeyi, Rahman Hameed Mohammed Abdul , Sonalben Chaudhary, Mohammed Qasim Rauf, Neelum Ali. Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Cureus 2025; doi: 10.7759/cureus.97094
|
| 9 |
Seyed Mohamad Musavi, Ali Afrasiabi. The global prevalence of non-alcoholic fatty liver disease and related terms in adults with inflammatory bowel disease: a systematic review and meta-analysis. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-026-00519-2
|
| 10 |
Aneta Sokal-Dembowska, Kübra Ergan, Sara Jarmakiewicz-Czaja. Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(40): 111375 doi: 10.3748/wjg.v31.i40.111375
|
| 11 |
Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea, Carol Stanciu. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter. Journal of Clinical Medicine 2022; 11(19) doi: 10.3390/jcm11195959
|
| 12 |
Yuyang Zhao, Jiangbin Wang, He Sun. Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1517462
|
| 13 |
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
|
| 14 |
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?. BIOCELL 2021; 45(3) doi: 10.32604/biocell.2021.014332
|
| 15 |
Somtochukwu Onwuzo, Antoine Boustany, Mustafa Saleh, Riya Gupta, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Favour Lawrence, Chukwuemeka Obuekwe, Zoya Morani, Imad Asaad. Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study. Cureus 2023; doi: 10.7759/cureus.35854
|
| 16 |
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Inflammatory Bowel Diseases 2023; 29(9) doi: 10.1093/ibd/izac189
|
| 17 |
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martinez, Jan Wisniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren, Susan E. Crawford, S. Patricia Becerra, Jimin Zhu, Taotao Liu, Sui Wang, Keji Zhao, Chuan Wu. Gut-liver axis calibrates intestinal stem cell fitness. Cell 2024; 187(4) doi: 10.1016/j.cell.2024.01.001
|
| 18 |
Dario Rahelić, Lucija Romić, Marija Martinović, Sanja Klobučar. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; doi: 10.1007/978-3-031-69800-2_24
|
| 19 |
Yejoo Jeon, Berkeley N Limketkai. Implications of Dietary Impact on Hepatic Steatosis and IBD. Inflammatory Bowel Diseases 2021; 27(1) doi: 10.1093/ibd/izaa098
|
| 20 |
Peter B. Soeters, Peter W. de Leeuw. Reciprocal Translation Between Pathophysiology and Practice in Health and Disease. 2021; doi: 10.1016/B978-0-12-820205-0.00002-5
|
| 21 |
Fabio Chicco, Salvatore Magrì, Arianna Cingolani, Danilo Paduano, Mario Pesenti, Federica Zara, Francesca Tumbarello, Emanuela Urru, Alessandro Melis, Laura Casula, Massimo Claudio Fantini, Paolo Usai. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflammatory Bowel Diseases 2021; 27(1) doi: 10.1093/ibd/izaa097
|
| 22 |
Şükran Aras. Determination of the effects of vitamin D and Nettle (Urtica Dioica L) extract administration on SOD-2 and TNF-α levels in liver tissue of TNBS (2,4,6 Trinitrobenzene sulfonic acid)-induced rats. Journal of Advances in VetBio Science and Techniques 2024; 9(3) doi: 10.31797/vetbio.1428195
|
| 23 |
Marcela A.B. Fagiani, Ana P.M. Andrade, Anna C.P. Pereira, Arthur S. Zulli, Bianca M.E. Estopa, Breno L.G. Rosa, Fabíola A. Mello, Gracielle V. Gonçalves, Isabella B. Ferreira, Liliane G. Pereira, Sandra C. Genaro, Cecília L. Santarém, Sabrina A. Lenquiste.
Tea from Pods with Seeds of
Libidibia ferrea
(Jucá) Does Not Attenuate Inflammatory Reaction of Acute Colitis in Rats
. Journal of Medicinal Food 2026; 29(7) doi: 10.1177/1096620X251385497
|
| 24 |
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
|
| 25 |
Elena Grueso Navarro, Alfredo J. Lucendo. Metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease: prevalence, risk factors, pathophysiological pathways and clinical consequences. Expert Review of Clinical Immunology 2025; 21(7) doi: 10.1080/1744666X.2025.2514605
|
| 26 |
Bo Shen, Junjun Wang, Yuecheng Guo, Tianyi Gu, Zhenyang Shen, Cui Zhou, Binghang Li, Xianjun Xu, Fei Li, Qidi Zhang, Xiaobo Cai, Hui Dong, Lungen Lu. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.756299
|
| 27 |
Lorenz M. W. Holzner, Andrew J. Murray. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.753268
|
| 28 |
D.N. Shintaku, M.A. Lopes, R.F. Beraldo, E.C.S. de Oliveira, G.S.P. Herrerias, A.C.B. de Oliveira, J.P. Baima, W.F. Barbosa, G.F. Silva, L.Y. Sassaki. Investigation of liver diseases using liver Doppler ultrasound in patients with inflammatory bowel diseases. Brazilian Journal of Medical and Biological Research 2025; 58 doi: 10.1590/1414-431x2025e14523
|
| 29 |
Zhaofeng Shen, Mengyuan Zhang, Yijing Liu, Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis. BMJ Open 2024; 14(3) doi: 10.1136/bmjopen-2023-074659
|
| 30 |
Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak. NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease. Inflammatory Bowel Diseases 2024; 30(5) doi: 10.1093/ibd/izad129
|
| 31 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Viviana Laredo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Julia López de la Cruz, Fernando Gomollón. Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review. Cancers 2023; 15(13) doi: 10.3390/cancers15133367
|
| 32 |
Khushbu Viresh Janani, Parsa Saberian, Hardik B. Patel, Narsimha Rao Keetha, Ardalan Etemadzadeh, Anya Patel, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Anoop Gurram. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale. Journal of Health, Population and Nutrition 2025; 44(1) doi: 10.1186/s41043-025-00860-z
|
| 33 |
Juan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, Marta Hernández-Conde, Coral Rivas-Rivas, María Isabel Vera, Maria Jose Garcia, Marta Pascual, Beatriz Castro, Agustín García-Blanco, Enrique García-Nieto, Soraya Curiel-del Olmo, María Luisa Cagigal, Lorena Lopez-Montejo, Tatiana Fernández-Lamas, Laura Rasines, José Ignacio Fortea, José Pedro Vaque, Yza Frias, Montserrat Rivero, María Teresa Arias-Loste, Javier Crespo. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors. Clinical Gastroenterology and Hepatology 2023; 21(2) doi: 10.1016/j.cgh.2022.01.039
|
| 34 |
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, Marija V. Zimkute, Negar Yaghooti, Christina L. Ling, Jessica M. Gross, Natalia Listwan, Sandra Cano, Vanessa Garcia, Debbie M. Lovato, Susan L. Tigert, Drew R. Jones, Rama R. Gullapalli, Neal E. Rakov, Euriko G. Torrazza Perez, Eliseo F. Castillo. Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. Metabolites 2022; 12(5) doi: 10.3390/metabo12050431
|
| 35 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3) doi: 10.3390/metabo13030378
|
| 36 |
Ali Abdulla, Ayan M. Sheikhnoor, Kevin Ferrao, Lucy I. Stiles, Kosha J. Mehta. Bidirectional interplay between gut and liver in inflammatory bowel disease and hepatobiliary conditions. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-026-02102-w
|
| 37 |
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
|
| 38 |
Narsimha Keetha Rao, Shahriar Ghodous, Anoop Gurram, Mehrdad Khorasani, Madhusudhan Ponnala, Arman Habibi, Kwame Agyeman, Parsa Saberian, Pubali Biswas, Negin Letafatkar, Simran Joshi, Yasmin Sahli, Reza Amani-Beni, Bahar Darouei, Yussif Issaka, Kiran Sandilya Balivada, Farahnaz Joukar, Amir Nasrollahizadeh, Anderson Ogazi, Mohammad Amin Karimi, Michael T Ulrich, Mohammad-Hossein Keivanlou, Mohammad-Javad Khosousi, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Sandeep S Nayak. Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: An Updated Global Systematic Review and Meta-Analysis of over 1.5 Million Individuals. Inflammatory Bowel Diseases 2026; 32(2) doi: 10.1093/ibd/izaf226
|
| 39 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2024; 120 doi: 10.1016/j.ejim.2023.10.019
|
| 40 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1) doi: 10.3390/gastroent14010002
|
| 41 |
Apostolis Papaefthymiou, Styliani Sarrou, Konstantinos Pateras, Ilias D. Vachliotis, Georgios Agrotis, Ioanna-Konstantina Sgantzou, Georgios Perifanos, Andreas Kapsoritakis, Matthaios Speletas, Marianna Vlychou, George N. Dalekos, Spyros Potamianos, Antonis Goulas, Jannis Kountouras, Stergios A. Polyzos. The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial. Pharmaceuticals 2024; 17(11) doi: 10.3390/ph17111432
|
| 42 |
Peter Hoffmann, Victoria Jung, Rouven Behnisch, Annika Gauss. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. World Journal of Gastroenterology 2020; 26(46): 7367-7381 doi: 10.3748/wjg.v26.i46.7367
|
| 43 |
E. van Lingen, M. E. Tushuizen, M. E. J. Steenhuis, T. van Deynen, J. Martens, D. Diaz-Infante Morales, A. E. van der Meulen-de Jong, I. Molendijk, S. van der Marel, P. W. J. Maljaars. Disease activity in inflammatory bowel disease patients is associated with increased liver fat content and liver fibrosis during follow-up. International Journal of Colorectal Disease 2022; 37(2) doi: 10.1007/s00384-021-04065-8
|
| 44 |
Meng-Yu Wang, Zi-Xuan Wang, Lei-Jie Huang, Rui-Xu Yang, Zi-Yuan Zou, Wen-Song Ge, Tian-Yi Ren, Jian-Gao Fan. Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice. Journal of Clinical and Translational Hepatology 2022; 10(5) doi: 10.14218/JCTH.2021.00315
|
| 45 |
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3) doi: 10.1093/ecco-jcc/jjad157
|
| 46 |
Pilar Navarro, Lucía Gutiérrez-Ramírez, Antonio Tejera-Muñoz, Ángel Arias, Alfredo J. Lucendo. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease. Nutrients 2023; 15(21) doi: 10.3390/nu15214507
|
| 47 |
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. Medicina 2023; 59(11) doi: 10.3390/medicina59111935
|
| 48 |
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh, Rohit Loomba. Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 55(8) doi: 10.1111/apt.16879
|
| 49 |
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; doi: 10.1007/978-3-031-14744-9_11
|
| 50 |
Giulia Gibiino, Alessandro Sartini, Stefano Gitto, Cecilia Binda, Monica Sbrancia, Chiara Coluccio, Vittorio Sambri, Carlo Fabbri. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(8) doi: 10.3390/nu13082772
|
| 51 |
Charalampia Amerikanou, Efstathia Papada, Aristea Gioxari, Ilias Smyrnioudis, Stamatia-Angeliki Kleftaki, Evdokia Valsamidou, Victoria Bruns, Rajarshi Banerjee, Maria Giovanna Trivella, Natasa Milic, Milica Medić-Stojanoska, Amalia Gastaldelli, Aimo Kannt, George V. Dedoussis, Andriana C. Kaliora. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacological Research 2021; 171 doi: 10.1016/j.phrs.2021.105753
|
| 52 |
Rossella Maresca, Irene Mignini, Simone Varca, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063278
|
| 53 |
Junhao Liu, Xiaodong Xu, Sijia Sun, Tiantian Zhou, Yimeng Cai, Zi Wang, Zhao Ding. Dietary succinoglycan riclin ameliorates spontaneous gut inflammation by restoring immune homeostasis in Period2-deficient mice. Journal of Functional Foods 2026; 138 doi: 10.1016/j.jff.2026.107198
|
| 54 |
Krishneel Dutt, Abhinav Vasudevan, Alexander Hodge, Tuan L Nguyen, Ashish R Srinivasan. Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review. World Journal of Gastroenterology 2025; 31(24): 107661 doi: 10.3748/wjg.v31.i24.107661
Abstract(296) |
Core Tip(317) |
Full Article(HTML)(2164)
|
Full Article (PDF)-1152K(244)
|
Full Article with Cover (PDF)-1368K(168)
|
Full Article (XML)-492K(98)
|
Audio-1310K(14)
|
Peer-Review Report-258K(88)
|
Answering Reviewers-103K(94)
|
Supplementary Material-193K(85)
|
Times Cited (4)
|
Total Visits (3064)
|
Open
|
| 55 |
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's and Colitis 2022; 16(5) doi: 10.1093/ecco-jcc/jjab212
|
| 56 |
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, Bobae Kim, Chang-Kee Hyun. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84761-1
|
| 57 |
Yejoo Jeon, Berkeley N. Limketkai. Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD. Digestive Diseases and Sciences 2021; 66(9) doi: 10.1007/s10620-020-06672-x
|
| 58 |
Cuauhtemoc B. Ramirez, In Sook Ahn, Varvara I. Rubtsova, Ingrid Cely, Johnny Le, Joohwan Kim, Sunhee Jung, Miranda E. Kelly, Yeojin Kim, Hosung Bae, Won-Suk Song, Yasmine H. Alam, Guanglin Zhang, Graciel Diamante, Alina Chao, Lauren Hoffner, Alexis Anica, Izabelle Le, Miranda L. Lopez, Ian J. Tamburini, Elena M. Moyer, Ariel Tsai, Qin Yang, Xing Dai, Daniele Piomelli, Gina Lee, Xia Yang, Cholsoon Jang. Circulating glycerate predicts resilience to fructose-induced hepatic steatosis. Cell Metabolism 2025; 37(5) doi: 10.1016/j.cmet.2025.03.017
|
| 59 |
Brian K. Do, Amer F. Alsoudi, Karen M. Wai, Euna Koo, Ryan A. McConnell, Nathan H. Pham, Andrea L. Kossler, Prithvi Mruthyunjaya, Ehsan Rahimy. Risk of intestinal complications, extraintestinal morbidity, and mortality in patients with ulcerative colitis and ocular involvement. Eye 2026; 40(2) doi: 10.1038/s41433-025-04151-z
|
| 60 |
Lixia Li, Xinting Lan, Xi Peng, Shuai Shi, Yanlin Zhao, Wentao Liu, Qihui Luo, Lanlan Jia, Bin Feng, Zhengli Chen, Yuanfeng Zou, Chao Huang. Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut–Liver Axis. International Journal of Molecular Sciences 2022; 23(18) doi: 10.3390/ijms231810620
|
| 61 |
Zixuan Zhong, Minxuan Xu, Chenxu Ge, Jun Tan. Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62310-w
|
| 62 |
Claudia Veltkamp, Shuai Lan, Eleni Korompoki, Karl-Heinz Weiss, Hartmut Schmidt, Helmut K. Seitz. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. Journal of Clinical Medicine 2022; 11(9) doi: 10.3390/jcm11092623
|
| 63 |
Manuela Cassotta, Danila Cianciosi, Rachele De Giuseppe, Maria Dolores Navarro-Hortal, Yasmany Armas Diaz, Tamara Yuliett Forbes-Hernández, Kilian Tutusaus Pifarre, Alina Eugenia Pascual Barrera, Giuseppe Grosso, Jianbo Xiao, Maurizio Battino, Francesca Giampieri. Possible role of nutrition in the prevention of inflammatory bowel disease–related colorectal cancer: A focus on human studies. Nutrition 2023; 110 doi: 10.1016/j.nut.2023.111980
|
| 64 |
Shun-Wen Hsiao, Ting-Chun Chen, Pei-Yuan Su, Chen-Ta Yang, Siou-Ping Huang, Yang-Yuan Chen, Hsu-Heng Yen. Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission. Diagnostics 2023; 13(20) doi: 10.3390/diagnostics13203268
|